Tolperisone--a novel modulator of ionic currents in myelinated axons.
The actions of tolperisone on single intact Ranvier nodes of the toad Xenopus were investigated by means of the Hodgkin-Huxley formalism. Adding tolperisone to the bathing medium (100 micromol/l) caused the following fully reversible effects: 1. The sodium permeability P'Na was decreased by about 50% in a nearly potential-independent manner while the so-called sodium inactivation curve was shifted in the negative direction by about 3 mV. 2. The remaining parameters of the sodium system, i.e. m, taum and tauh, did not change. 3. The potassium permeability P'K decreased at strong depolarizing potentials (V > 60 mV); hence the permeability constant P(K) decreased by about 8%. However, weak depolarizations (V < 60 mV) caused P'K to increase by about 7%. 4. The potassium activation curve was shifted in the positive direction by about 9 mV and the exponent of n, b, was reduced from about 3.5 to about 1.5. Concentration-response relations for reduction of the sodium permeability constant PNa and of the potassium permeability constant P(K) yielded apparent dissociation constants of about 0.06 mmol/l and 0.32 mmol/l, respectively. The increase of P'K at V = 40 mV, however, was largely concentration-independent. Our findings show that, in contrast to the prevailing view, tolperisone cannot be said to have a so-called lidocaine-like activity, because its effect on potassium permeability in the threshold region is fundamentally different from that of other known local anaesthetics. We infer that this effect, in combination with the decrease in sodium permeability, is responsible for the tendency of tolperisone to reduce excitability and hence for the antispastic action of tolperisone documented by clinical observations.
Hinck
D
D
Institute of Physiology, University of Kiel, Germany.
Koppenhöfer
E
E
D000818:Animals; D001369:Axons / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D007477:Ions; D007700:Kinetics; D008956:Models, Chemical; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D009186:Myelin Sheath / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism; D011901:Ranvier's Nodes / Q000187:drug effects*; D012964:Sodium / Q000378:metabolism; D014049:Tolperisone / Q000494:pharmacology*; D014981:Xenopus
D007477:Ions; D009125:Muscle Relaxants, Central; D012964:Sodium; D014049:Tolperisone; D011188:Potassium